No Such Thing as a Shark? Genomes Shake up Ocean Predator’s Family Tree

Why It Matters

Accurate shark phylogeny informs evolutionary biology, conservation strategies, and biomedical research that relies on shark genetics. Redefining sharks as a paraphyletic group could reshape taxonomy and affect regulatory frameworks for species protection.

Key Takeaways

• Ultra‑conserved DNA shows sharks are paraphyletic.
• Hexanchiformes form a lineage separate from other sharks.
• Rays and skates may have evolved from shark ancestors.
• Protein‑coding genes still support traditional monophyletic sharks.
• More genome data needed to confirm shark evolutionary tree.

Pulse Analysis

Sharks, rays, and skates belong to the cartilaginous class Chondrichthyes, a lineage that diverged from bony fish over 400 million years ago. Traditional classifications relied on skeletal morphology and limited genetic markers, often grouping all shark‑like species together. Recent advances in whole‑genome sequencing now allow scientists to compare thousands of conserved elements across species, offering a finer resolution of evolutionary relationships that older methods could not achieve.

The Yale team’s analysis of 48 genomes uncovered a striking split: while 840 shared protein‑coding genes reinforced the classic view of a monophyletic shark clade, about 350 ultra‑conserved regions painted a different picture. Those regions placed hexanchiform sharks—such as cow and frilled sharks—on a separate branch, implying that the majority of species called “sharks” are more closely aligned with rays and skates. This paraphyletic scenario suggests that the iconic flat‑bodied rays may have originated from shark‑like ancestors, flipping a long‑held assumption about the direction of morphological evolution within Chondrichthyes.

Beyond academic intrigue, a revised shark phylogeny carries practical weight. Conservation policies often target taxonomic groups; redefining sharks could shift protection priorities for vulnerable ray species. Moreover, shark genomes are a source of novel bioactive compounds and insights into cancer resistance, so understanding their true evolutionary context can guide biomedical discovery. The study underscores the need for expanded sampling—especially of understudied deep‑sea species—and integration of diverse genomic markers before the scientific community settles on a definitive shark family tree.